TNF Pharmaceuticals, Inc.
TNFA
$0.22
$0.02814.58%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 73.03% | 25.60% | 12.38% | -88.84% | 1.80% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 0.06% | 9.62% | -14.80% | -1.75% | 57.86% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 61.82% | 23.53% | 9.24% | -84.89% | 7.67% |
|
|
|||||
| Total Current Assets | 61.82% | 23.53% | 9.24% | -84.89% | 7.67% |
| Net Property, Plant & Equipment | -77.64% | -79.87% | -76.02% | -71.81% | -66.07% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 19.92% | 10.16% | 4.49% | -48.98% | 1.84% |
|
|
|||||
| Total Accounts Payable | -18.31% | 174.88% | 146.67% | 179.35% | 30.66% |
| Total Accrued Expenses | -39.30% | -33.63% | 5.43% | 200.77% | 101.17% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -78.32% | -74.79% | -63.30% | -47.06% | -25.68% |
| Total Finance Division Other Current Liabilities | 209.79% | -21.71% | 463.49% | -59.75% | 3,976.67% |
| Total Other Current Liabilities | 209.79% | -21.71% | 463.49% | -59.75% | 3,976.67% |
| Total Current Liabilities | 34.35% | 22.70% | 138.06% | 144.42% | 80.14% |
|
|
|||||
| Total Current Liabilities | 34.35% | 22.70% | 138.06% | 144.42% | 80.14% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | 79.26% | -97.80% | -- |
| Total Liabilities | 31.69% | 22.26% | 89.14% | -70.47% | 78.87% |
|
|
|||||
| Common Stock & APIC | 21.52% | 26.85% | 11.49% | 13.28% | 5.44% |
| Retained Earnings | -26.63% | -29.78% | -23.36% | -18.39% | -8.77% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -21.10% | 8.31% | -100.44% | -24.37% | -15.98% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 824.99% | -43.94% | -52.61% | -57.64% | 279.65% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 824.99% | -43.94% | -52.61% | -57.64% | 279.65% |
|
|
|||||
| Total Common Equity | -21.10% | 8.31% | -100.44% | -24.37% | -15.98% |
| Total Preferred Equity | 824.99% | -43.94% | -52.61% | -57.64% | 279.65% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 15.24% | 5.87% | -96.68% | -26.89% | -13.08% |
|
|
|||||